6533b82ffe1ef96bd129599c
RESEARCH PRODUCT
444P PRODIGE 25 (FFCD 11-01)-FOLFA: A randomized phase II trial evaluating aflibercept associated with LV5FU2 regimen as first-line treatment of non-resectable metastatic colorectal cancers
F. Khemissa AkouzJoëlle EgreteauK. Le MalicotVincent BourgeoisNicolas BarriereM. BaconnierJean-louis LegouxDavid MalkaThomas AparicioV. LorgisVeronique Guerin-meyerDavid TougeronValérie BoigeV. Lebrun-lyRoger FarouxCôme Lepagesubject
First line treatmentOncologymedicine.medical_specialtyRegimenOncologybusiness.industryInternal medicinemedicineHematologybusinessAfliberceptmedicine.drugyear | journal | country | edition | language |
---|---|---|---|---|
2020-09-01 | Annals of Oncology |